Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1967 1
1970 1
1971 2
1972 3
1973 2
1974 7
1975 2
1976 4
1977 3
1978 2
1979 2
1980 4
1981 6
1982 1
1983 3
1984 4
1985 6
1986 5
1987 5
1988 5
1989 7
1990 6
1991 11
1992 11
1993 11
1994 10
1995 13
1996 13
1997 21
1998 11
1999 19
2000 13
2001 19
2002 14
2003 18
2004 23
2005 18
2006 14
2007 22
2008 24
2009 20
2010 23
2011 27
2012 23
2013 30
2014 29
2015 32
2016 24
2017 20
2018 32
2019 14
2020 24
2021 19
2022 17
2023 10
2024 6

Text availability

Article attribute

Article type

Publication date

Search Results

659 results

Results by year

Filters applied: . Clear all
Page 1
Pathophysiology of diabetic kidney disease: impact of SGLT2 inhibitors.
DeFronzo RA, Reeves WB, Awad AS. DeFronzo RA, et al. Nat Rev Nephrol. 2021 May;17(5):319-334. doi: 10.1038/s41581-021-00393-8. Epub 2021 Feb 5. Nat Rev Nephrol. 2021. PMID: 33547417 Review.
The quantitative contribution of each of these abnormalities to the progression of diabetic kidney disease, as well as their role in type 1 and type 2 diabetes mellitus, remains to be determined. Sodium-glucose co-transporter 2 (SGLT2) inhibitors have a beneficial impact o …
The quantitative contribution of each of these abnormalities to the progression of diabetic kidney disease, as well as their role in …
Vascular pathologies in chronic kidney disease: pathophysiological mechanisms and novel therapeutic approaches.
Düsing P, Zietzer A, Goody PR, Hosen MR, Kurts C, Nickenig G, Jansen F. Düsing P, et al. J Mol Med (Berl). 2021 Mar;99(3):335-348. doi: 10.1007/s00109-021-02037-7. Epub 2021 Jan 22. J Mol Med (Berl). 2021. PMID: 33481059 Free PMC article. Review.
While numerous risk factors promote atherosclerosis by inducing endothelial dysfunction and its progress to vascular structural damage, CKD affects the medial layer of blood vessels primarily through VC. Ongoing research has identified VC to be a multifactori …
While numerous risk factors promote atherosclerosis by inducing endothelial dysfunction and its progress to vascular structural damag …
Pathophysiology of Calcium, Phosphorus, and Magnesium Dysregulation in Chronic Kidney Disease.
Felsenfeld AJ, Levine BS, Rodriguez M. Felsenfeld AJ, et al. Semin Dial. 2015 Nov-Dec;28(6):564-77. doi: 10.1111/sdi.12411. Epub 2015 Aug 25. Semin Dial. 2015. PMID: 26303319 Review.
Increased parathyroid hormone (PTH) secretion maintains serum calcium normal by increasing calcium efflux from bone, renal calcium reabsorption, and phosphate excretion. Similarly, renal phosphate excretion in CKD is maintained by increased secretion of fibroblast g …
Increased parathyroid hormone (PTH) secretion maintains serum calcium normal by increasing calcium efflux from bone, renal calcium re …
A review of clinical characteristics and genetic backgrounds in Alport syndrome.
Nozu K, Nakanishi K, Abe Y, Udagawa T, Okada S, Okamoto T, Kaito H, Kanemoto K, Kobayashi A, Tanaka E, Tanaka K, Hama T, Fujimaru R, Miwa S, Yamamura T, Yamamura N, Horinouchi T, Minamikawa S, Nagata M, Iijima K. Nozu K, et al. Clin Exp Nephrol. 2019 Feb;23(2):158-168. doi: 10.1007/s10157-018-1629-4. Epub 2018 Aug 20. Clin Exp Nephrol. 2019. PMID: 30128941 Free PMC article. Review.
Alport syndrome (AS) is a progressive hereditary renal disease that is characterized by sensorineural hearing loss and ocular abnormalities. ...Because of these advances, substantial information about the genetics of AS has been obtained and the genetic background o …
Alport syndrome (AS) is a progressive hereditary renal disease that is characterized by sensorineural hearing loss and ocular abno
Augmenting Anticancer Immunity Through Combined Targeting of Angiogenic and PD-1/PD-L1 Pathways: Challenges and Opportunities.
Hack SP, Zhu AX, Wang Y. Hack SP, et al. Front Immunol. 2020 Nov 5;11:598877. doi: 10.3389/fimmu.2020.598877. eCollection 2020. Front Immunol. 2020. PMID: 33250900 Free PMC article. Review.
Angiogenic factors such as vascular endothelial growth factor (VEGF) drive immunosuppression in the TME by inducing vascular abnormalities, suppressing antigen presentation and immune effector cells, or augmenting the immune suppressive activity of regulatory …
Angiogenic factors such as vascular endothelial growth factor (VEGF) drive immunosuppression in the TME by inducing vascular
Familial Hyperparathyroidism.
Blau JE, Simonds WF. Blau JE, et al. Front Endocrinol (Lausanne). 2021 Feb 25;12:623667. doi: 10.3389/fendo.2021.623667. eCollection 2021. Front Endocrinol (Lausanne). 2021. PMID: 33716975 Free PMC article. Review.
Regulation of the serum calcium level in humans is achieved by the endocrine action of parathyroid glands working in concert with vitamin D and a set of critical target cells and tissues including osteoblasts, osteoclasts, the renal tubules, and the small intestine. The pa …
Regulation of the serum calcium level in humans is achieved by the endocrine action of parathyroid glands working in concert with vitamin D …
Bone-vascular cross-talk.
London GM. London GM. J Nephrol. 2012 Sep-Oct;25(5):619-25. doi: 10.5301/jn.5000187. J Nephrol. 2012. PMID: 22711433 Review.
Increasing numbers of cross-sectional studies on general populations and chronic kidney disease (CKD) or end-stage renal disease (ESRD) patients have reported relationships between cardiovascular calcifications and bone disorders, including osteoporosis, osteopenia and hig …
Increasing numbers of cross-sectional studies on general populations and chronic kidney disease (CKD) or end-stage renal disease (ESR …
Drug-induced scleroderma-like lesion.
Hamaguchi Y. Hamaguchi Y. Allergol Int. 2022 Apr;71(2):163-168. doi: 10.1016/j.alit.2021.08.005. Epub 2021 Aug 28. Allergol Int. 2022. PMID: 34465533 Free article. Review.
Drug-induced scleroderma-like lesion differs from systemic sclerosis in that it does not include Raynaud's phenomenon, nail-fold capillary abnormality, organ involvement, such as reflux esophagitis, interstitial pneumonia, renal crisis, or anti-nuclear Abs. ...
Drug-induced scleroderma-like lesion differs from systemic sclerosis in that it does not include Raynaud's phenomenon, nail-fold capillary …
Retroperitoneoscopic heminephrectomy.
Taghavi K, Mushtaq I. Taghavi K, et al. J Pediatr Urol. 2018 Apr;14(2):196-197. doi: 10.1016/j.jpurol.2018.02.010. Epub 2018 Mar 7. J Pediatr Urol. 2018. PMID: 29551554 Review.
The vital first step is a 'critical view' of the collecting system/vascular supply of both upper/lower moieties. Dividing the lateral renal attachments later in the dissection allows passive retraction of the hilum, facilitating this dissection....
The vital first step is a 'critical view' of the collecting system/vascular supply of both upper/lower moieties. Dividing the lateral …
Von Hippel-Lindau Syndrome.
Ben-Skowronek I, Kozaczuk S. Ben-Skowronek I, et al. Horm Res Paediatr. 2015;84(3):145-52. doi: 10.1159/000431323. Epub 2015 Aug 5. Horm Res Paediatr. 2015. PMID: 26279462 Free article. Review.
Von Hippel-Lindau (VHL) disease is a hereditary cancer syndrome characterized by the development of multiple vascular tumours. The syndrome is caused by inactivation of the VHL protein (pVHL) and increased production of VEGF, PDGF, and TGF-alpha. The course of VHL syndrome …
Von Hippel-Lindau (VHL) disease is a hereditary cancer syndrome characterized by the development of multiple vascular tumours. The sy …
659 results